The effect of luseogliflozin and alpha-glucosidase inhibitor on heart failure with preserved ejection fraction in diabetic patients: rationale and design of the MUSCAT-HF randomised controlled trial

INTRODUCTION: Type 2 diabetes mellitus (T2DM) is a strong risk factor for coronary artery disease and heart failure, particularly heart failure with preserved ejection fraction (HFpEF). The aim of the ongoing MUSCAT-HF (It stands for Prospective Comparison of Luseogliflozin and Alpha-glucosidase on...

Descripción completa

Detalles Bibliográficos
Autores principales: Ejiri, Kentaro, Miyoshi, Toru, Nakamura, Kazufumi, Sakuragi, Satoru, Munemasa, Mitsuru, Namba, Seiji, Takaishi, Atsushi, Ito, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475163/
https://www.ncbi.nlm.nih.gov/pubmed/30928954
http://dx.doi.org/10.1136/bmjopen-2018-026590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475163/
https://www.ncbi.nlm.nih.gov/pubmed/30928954
http://dx.doi.org/10.1136/bmjopen-2018-026590

Ejemplares similares